Health & Medical Heart Diseases

Race, Exercise Training, and Outcomes in Chronic HF

Race, Exercise Training, and Outcomes in Chronic HF

Results


Of patients who self-reported race (n = 2,296), 33% (n = 749) were black. Table I presents baseline characteristics. Blacks were younger, were more often female, and had less ischemic etiology and lower socioeconomic status versus whites. Blacks also tended to have higher body mass index (BMI) and more hypertension and diabetes but less atrial fibrillation. Blacks had shorter 6-minute walk distance and lower peak VO2 at baseline; ( Table II ). Differences in these exercise-testing parameters remained significant after adjustment for sex differences (both P < .01). More than 90% of black and white patients were receiving angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers, with approximately half as many receiving aldosterone antagonists. Combination hydralazine/nitrate use was greater in blacks than in whites. Blacks were less likely to have an implanted cardioverter/defibrillator (ICD) or cardiac resynchronization therapy (CRT) device; however, there were significant differences in conduction pattern by race. Specifically, more blacks had normal ventricular conduction, and fewer blacks had bundle-branch block morphology (14.7% vs 22.9%).

Adherence to exercise training by exercise minutes per week during the first 3 months and months 10 to 12 was 63 (18–106) in blacks versus 86 (50–125) in nonblacks (P < .001) and 68 (6–167) versus 108 (26–208) (P < .001), respectively. Median exercise volume in the exercise training arm was lower in blacks than in whites (2.9 [1.0–5.0] vs 4.4 [2.4–6.6] MET-h/wk, respectively, during months 1–3).

Overall adverse events were similar in patients of different race (online Appendix Supplementary Table I ), with the exception of more worsening HF in blacks than in whites (36% vs 24%).

Mode-specific event rates for death and hospitalization are presented in the online Appendix Supplementary Table II . Over a median follow-up of 2.5 years, all-cause mortality was 17.9% in blacks and 15.8% in whites. Hospitalization occurred in 67.0% of blacks versus 62.1% of whites. Nearly half of all hospitalizations were for HF in blacks (48.4%) compared with approximately a third in whites (33.9%). Black race was associated with increased mortality/hospitalization and cardiovascular mortality/HF hospitalization ( Table III ). All-cause mortality was similar in black and white patients. Cardiovascular mortality was similar between groups (P = .21), whereas black race was associated with increased hazard for HF hospitalization (HR 1.62, 95% CI 1.37–1.92) (online Appendix Supplementary Table III ).

After multivariable adjustment for the adjustment model covariates, black race remained associated with increased mortality/hospitalization and cardiovascular mortality/HF hospitalization ( Table III ). Figure 1 displays adjusted event curves for the endpoints of mortality/hospitalization, and cardiovascular mortality/HF hospitalization. Exploring the individual components of these end points suggested increased risk, associated with black race for HF hospitalization (adjusted HR 1.58, 95% CI 1.27–1.96), but similar risk for cardiovascular mortality (adjusted P = .18).

After adjustment for additional socioeconomic covariates, black race was no longer associated with a significant increase in mortality/hospitalization (P = .09). The increased risk of cardiovascular mortality/HF hospitalization ( Table III ) and the individual component of HF hospitalization associated with black race remained statistically significant (HR 1.55, 95% CI 1.22–1.97) ( Appendix Supplementary Table III ).

There was no interaction between race and assignment to exercise training on clinical outcomes ( Table IV ). However, there was evidence for an interaction between black race and exercise training for change in 6-minute walk distance (adjusted P = .02). The estimated improvement in 6-minute walk distance with exercise training versus usual care at 3 months was +26 m (95% CI, +18 to +34) in whites versus +11 m (95% CI, 0 to +21) in blacks. No other exercise or health status variable demonstrated a statistically significant interaction with race and exercise training.

SHARE
RELATED POSTS on "Health & Medical"
Sparking Innovation: Patients First, Mice Second
Sparking Innovation: Patients First, Mice Second
Beating Heart Disease the Natural Way!
Beating Heart Disease the Natural Way!
Review of Robotic-Assisted, Totally Endoscopic CABG
Review of Robotic-Assisted, Totally Endoscopic CABG
Lower LDL Cholesterol Naturally
Lower LDL Cholesterol Naturally
What is a Good Ratio For LDL to HDL? A Simple Guide
What is a Good Ratio For LDL to HDL? A Simple Guide
Homocysteine Danger Seems to Be Ignored by Doctors
Homocysteine Danger Seems to Be Ignored by Doctors
City Dwellers Have More Heart Disease
City Dwellers Have More Heart Disease
Warning Signs of Heart Disease in Women
Warning Signs of Heart Disease in Women
fish oil infused vegetables
fish oil infused vegetables
Tips For a Healthy Heart
Tips For a Healthy Heart
Understanding Diagnosis and Treatment of Aneurysms
Understanding Diagnosis and Treatment of Aneurysms
Cutting Balloon Angioplasty for Underexpanded Stent
Cutting Balloon Angioplasty for Underexpanded Stent
Five Ways To Lower Cholesterol - And A Case History
Five Ways To Lower Cholesterol - And A Case History
VTE in Primary Care: Patient Management With Rivaroxaban
VTE in Primary Care: Patient Management With Rivaroxaban
What Are the Key Symptoms of Heart Disease?
What Are the Key Symptoms of Heart Disease?
A Few Whiffs of Smoke May Harm Your Heart
A Few Whiffs of Smoke May Harm Your Heart
Giant Cell Myocarditis
Giant Cell Myocarditis
Vitamin C Heart Disease Cure
Vitamin C Heart Disease Cure
Kexin Type 9 Inhibitor Alirocumab in High Risk Patients
Kexin Type 9 Inhibitor Alirocumab in High Risk Patients
Discover How to Lower Cholesterol - Important Techniques For You to Use
Discover How to Lower Cholesterol - Important Techniques For You to Use
Managing Hypertension, Part I: Diuretics
Managing Hypertension, Part I: Diuretics
SAPIEN Transcatheter Heart Valve for High-Risk Aortic Stenosis
SAPIEN Transcatheter Heart Valve for High-Risk Aortic Stenosis

Leave Your Reply

*